Carl Zeiss Meditec AG

1AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,784

Stocks News & Analysis

stocks

Hostile takeover on the cards for this ASX income opportunity

IFM lobs reasonable takeover offer.
stocks

Get ready for major US tech earnings starting tomorrow morning

Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.
stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.7016.000.18%
CAC 408,072.1331.96-0.39%
DAX 4023,954.5663.70-0.27%
Dow JONES (US)48,861.81280.12-0.57%
FTSE 10010,213.11119.68-1.16%
HKSE26,111.84432.061.68%
NASDAQ24,673.249.440.04%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,770.305.900.05%
S&P 5007,135.952.85-0.04%
S&P/ASX 2008,687.009.400.11%
SSE Composite Index4,107.5128.880.71%

Market Movers